Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘RA Capital’

RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains

According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (......(read more)

RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech

The biotechnology industry is up by more than 50% over the last year, but these towering returns don’t come without great risk and volatility. However......(read more)

Peter Kolchinsky, Ra Capital Management Inrease Stake in Achillion Pharmaceuticals Again

Peter Kolchinsky‘s hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.......(read more)

Peter Kolchinsky’s RA Capital Has Been Very Active This Month

Since the beginning of November, Peter Kolchinsky‘s RA Capital Management has informed the U.S. Securities and Exchange Commission that it’......(read more)
Barry Rosenstein JANA PARTNERS

Outerwall, Pandora & Achillion All Targets of Mega-Hedge Funds

 Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here). While a good portion......(read more)

Peter Kolchinsky’s Biotech Fund Doubles Achillion Pharmaceuticals Position

RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky‘s RA Capital disclosed that it owns nearly 15% of infectious......(read more)